We are upgrading the repository! A content freeze is in effect until December 6th, 2024 - no new submissions will be accepted; however, all content already published will remain publicly available. Please reach out to repository@u.library.arizona.edu with your questions, or if you are a UA affiliate who needs to make content available soon. Note that any new user accounts created after September 22, 2024 will need to be recreated by the user in November after our migration is completed.
Predictive network analysis identifies JMJD6 and other potential key drivers in Alzheimer’s disease
Name:
s42003-023-04791-5.pdf
Size:
7.146Mb
Format:
PDF
Description:
Final Published Version
Author
Merchant, J.P.Zhu, K.
Henrion, M.Y.R.
Zaidi, S.S.A.
Lau, B.
Moein, S.
Alamprese, M.L.
Pearse, R.V., II
Bennett, D.A.
Ertekin-Taner, N.
Young-Pearse, T.L.
Chang, R.
Affiliation
The Center for Innovation in Brain Sciences, University of ArizonaArizona Research Labs, Genetics Core, University of Arizona
Department of Neurology, University of Arizona
Issue Date
2023-05-15
Metadata
Show full item recordPublisher
Nature ResearchCitation
Merchant, J.P., Zhu, K., Henrion, M.Y.R. et al. Predictive network analysis identifies JMJD6 and other potential key drivers in Alzheimer’s disease. Commun Biol 6, 503 (2023). https://doi.org/10.1038/s42003-023-04791-5Journal
Communications BiologyRights
© The Author(s) 2023. This article is licensed under a Creative Commons Attribution 4.0 International License.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Despite decades of genetic studies on late-onset Alzheimer’s disease, the underlying molecular mechanisms remain unclear. To better comprehend its complex etiology, we use an integrative approach to build robust predictive (causal) network models using two large human multi-omics datasets. We delineate bulk-tissue gene expression into single cell-type gene expression and integrate clinical and pathologic traits, single nucleotide variation, and deconvoluted gene expression for the construction of cell type-specific predictive network models. Here, we focus on neuron-specific network models and prioritize 19 predicted key drivers modulating Alzheimer’s pathology, which we then validate by knockdown in human induced pluripotent stem cell-derived neurons. We find that neuronal knockdown of 10 of the 19 targets significantly modulates levels of amyloid-beta and/or phosphorylated tau peptides, most notably JMJD6. We also confirm our network structure by RNA sequencing in the neurons following knockdown of each of the 10 targets, which additionally predicts that they are upstream regulators of REST and VGF. Our work thus identifies robust neuronal key drivers of the Alzheimer’s-associated network state which may represent therapeutic targets with relevance to both amyloid and tau pathology in Alzheimer’s disease. © 2023, The Author(s).Note
Open access journalISSN
2399-3642PubMed ID
37188718Version
Final Published Versionae974a485f413a2113503eed53cd6c53
10.1038/s42003-023-04791-5
Scopus Count
Collections
Except where otherwise noted, this item's license is described as © The Author(s) 2023. This article is licensed under a Creative Commons Attribution 4.0 International License.
Related articles
- Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
- Authors: Ochalek A, Mihalik B, Avci HX, Chandrasekaran A, Téglási A, Bock I, Giudice ML, Táncos Z, Molnár K, László L, Nielsen JE, Holst B, Freude K, Hyttel P, Kobolák J, Dinnyés A
- Issue date: 2017 Dec 1
- The familial Alzheimer's disease APPV717I mutation alters APP processing and Tau expression in iPSC-derived neurons.
- Authors: Muratore CR, Rice HC, Srikanth P, Callahan DG, Shin T, Benjamin LN, Walsh DM, Selkoe DJ, Young-Pearse TL
- Issue date: 2014 Jul 1
- Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells.
- Authors: Israel MA, Yuan SH, Bardy C, Reyna SM, Mu Y, Herrera C, Hefferan MP, Van Gorp S, Nazor KL, Boscolo FS, Carson CT, Laurent LC, Marsala M, Gage FH, Remes AM, Koo EH, Goldstein LS
- Issue date: 2012 Jan 25
- A three-dimensional human neural cell culture model of Alzheimer's disease.
- Authors: Choi SH, Kim YH, Hebisch M, Sliwinski C, Lee S, D'Avanzo C, Chen H, Hooli B, Asselin C, Muffat J, Klee JB, Zhang C, Wainger BJ, Peitz M, Kovacs DM, Woolf CJ, Wagner SL, Tanzi RE, Kim DY
- Issue date: 2014 Nov 13
- Stabilizing the Retromer Complex in a Human Stem Cell Model of Alzheimer's Disease Reduces TAU Phosphorylation Independently of Amyloid Precursor Protein.
- Authors: Young JE, Fong LK, Frankowski H, Petsko GA, Small SA, Goldstein LSB
- Issue date: 2018 Mar 13